RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
ALISO VIEJO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated […]
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
SAN DIEGO, Feb. 14, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter […]
Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease
-Highlights potential uses of Celularity biomaterials in regenerative medicine applications that combine stem cells and biomaterial scaffolds for use in […]
SuRo Capital Corp. Will Commence a Modified Dutch Auction Tender Offer to Repurchase up to 2 Million Shares of its Common Stock
NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: […]
iPower Reports Fiscal Second Quarter 2024 Results
DUARTE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven […]
Veeco Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Fourth Quarter 2023 Highlights: Revenue of $173.9 million, compared with $153.8 million in the same period last year GAAP net […]
Enphase Energy Applauds Dutch Senate’s Decision to Extend Solar Net Metering
FREMONT, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the […]
Oaktree Specialty Lending Corporation Announces Tax Character of Distributions for Calendar Year 2023
LOS ANGELES, CA, Feb. 14, 2024 (GLOBE NEWSWIRE) — Oaktree Specialty Lending Corporation (NASDAQ:OCSL) (“OCSL” or the “Company”) today announced […]
Prime Medicine Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a […]
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) — Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare […]
